Extended Follow-Up of a Phase 2 Trial of Xevinapant Plus Chemoradiotherapy in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: a Randomised Clinical Trial. Yungan Tao , Xu-Shan Sun , Yoann Pointreau , Christophe Le Tourneau , Christian Sire , Marie-Christine Kaminsky , Alexandre Coutte , Marc Alfonsi , Benoit Calderon , Pierre Boisselier , Laurent Martin , Jessica Miroir , Jean-Francois Ramee , Jean-Pierre Delord , Florian Clatot , Frederic Rolland , Julie Villa , Nicolas Magne , Olgun Elicin , Elisabeta Gherga , France Nguyen , Cedrik Lafond , Guillaume Bera , Valentin Calugaru , Lionnel Geoffrois , Bruno Chauffert , Lars Damstrup , Philippa Crompton , Abdallah Ennaji , Kathrin Gollmer , Heidi Nauwelaerts , Jean Bourhis European journal of cancer（2023）
关键词
Xevinapant, Chemoradiotherapy, Locally advanced squamous cell carcinoma of the head and neck, Survival, Efficacy
AI 理解论文
溯源树
样例
